Corydalis crispa
What's the taxonomical classification of Corydalis crispa?
Corydalis crispa belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within the class Equisetopsida and the subclass Magnoliidae, it is positioned in the order Ranunculales. This plant is a member of the family Papaveraceae, falling under the genus Corydalis, and is specifically identified by the species name crispa.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Papaveraceae |
| Genus | Corydalis |
| Species | crispa |
What are the morphological characteristics of this plant?
Corydalis crispa has deeply lobed, bluish-green leaves with highly undulate or wavy margins and a basal rosette growth habit. The foliage consists of compound leaves that are divided into several distinct segments. Slender, upright stems emerge from the center of the rosette to support the flowering structures. The plant produces small, zygomorphic flowers that typically display a pale blue or lavender hue. Long, nectar-filled spurs extend from the back of each individual blossom. The overall structure is delicate and spreading, allowing it to colonize moist, shaded woodland soils.
What is the geographical distribution of this plant?
This plant is native to the mountainous regions of Central and Southern Europe, spanning from France and Switzerland through the Alps to the Balkan Peninsula. It typically thrives in specific habitats such as shaded deciduous forests, rocky slopes, and limestone-rich meadows. Its range is often limited to higher elevations where the soil remains moist and cool. Local populations can be found in various countries including Italy, Austria, and Slovenia. The distribution of this species is closely tied to the presence of calcareous substrates.
How is this plant cultivated?
This plant Corydalis crispa grows best in moist, humus-rich soil within partial shade or dappled sunlight.
It thrives in temperate climates where the ground remains consistently damp but well-drained to prevent root rot. Spring-blooming perennials like this one benefit from being planted in woodland garden settings that mimic their natural habitat. Once established, they require minimal maintenance beyond regular watering during dry spells.
Careful monitoring of soil moisture ensures the plant remains vigorous throughout its growing season.
What parts of this plant are used medicinally?
Corydalis crispa contains medicinal alkaloids primarily located within its underground rhizomes. These tuberous structures serve as the main source for extracting bioactive compounds used in traditional treatments. Practitioners specifically target the rhizomes to obtain isoquinoline alkaloids that exhibit sedative and analgesic properties. The chemical constituents within these roots are believed to influence the central nervous system to alleviate pain. Proper harvesting and processing of the rhizomes are essential to ensure the potency of the medicinal extracts.
What traditional systems uses this plant?
This plant Corydalis crispa has been utilized historically in various traditional medical systems to treat inflammatory conditions and neurological disorders. In Bhutanese Traditional Medicine, the plant is integrated into specialized formulations designed to balance bodily energies and alleviate specific ailments. Practitioners have long relied on its bioactive alkaloids to manage pain and soothe digestive issues. Beyond the Himalayan regions, other historical traditions have employed its rhizomes for their sedative and analgesic properties. These diverse applications highlight the long-standing botanical significance of the species in global ethnobotanical practices.
According to a study published by "Journal of ethnopharmacology", Corydalis crispa is used in the Bhutanese Traditional Medicine (BTM) for the management of different types of disorders, including diseases that bear relevance to various inflammatory conditions. This plant was one of 7 selected medicinal plants used in BTM for these purposes. In the study, crude extracts of the plant were prepared using 4 different solvents, including methanol, hexane, dichloromethane and chloroform. Among the 6 plants that inhibited the production of the pro-inflammatory cytokine TNF-α in LPS-activated THP-1 monocytic cells, Corydalis crispa gave the best inhibitory activity. These findings rationalize its traditional use in the BTM as an individual plant or in combination with other ingredients for the treatment of inflammatory conditions.
The hystorical systems that uses this plant are shown in the list below.
- Bhutanese Traditional Medicine
What are the pharmacological activities of Corydalis crispa?
This plant has acetylcholinesterase inhibitory, anti-inflammatory, immunomodulatory, antiplasmodial, and anthelmintic pharmacological activities. Its ability to inhibit acetylcholinesterase makes it a significant subject of study for neurodegenerative conditions. The anti-inflammatory and immunomodulatory properties suggest that its extracts can help regulate various immune responses within the body. Additionally, the plant demonstrates antiplasmodial activity which can assist in the management of certain parasitic infections. Finally, its anthelmintic effects provide a natural mechanism for combating intestinal worms.
According to a study published by "Natural product communications", the phytochemical study of Corydalis crispa resulted in the isolation of nine known isoquinoline alkaloids, specifically protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine (5), rheagenine (6), ochrobirine (7), sibiricine (8) and bicuculliine (9). Crude extracts of the plant exhibited significant anti-inflammatory (p < 0.01) activity against TNF-alpha production in LPS activated THP-1 cells. The acetylcholinesterase inhibitory activity was identified in compounds 2, 4 and 7. Additionally, compound 5 demonstrated antiplasmodial activity against P. falciparum strains TM4/8.2 and K1CB1, which is a multidrug resistant strain. While stylopine (4) did not show antimalarial activity against the K1CB1 strain, compound 5 was identified as a potential new antimalarial lead compound.
The primary pharmacological activities of this plant are shown in the list below.
- acetylcholinesterase inhibitory activity
- anti-inflammatory
- immunomodulatory
- antiplasmodial activity
- anthelmintiic
What medicinal compounds this plant contains?
This plant contains the medicinal alkaloids 13-oxocryptopine, 13-oxoprotopine, 14-O-acetylneoline, protopine, and sibiricine. These bioactive compounds are primarily categorized as benzylisoquinoline alkaloids. They are studied for their potential pharmacological effects on the central nervous system. Scientific research often focuses on how these specific molecules interact with biological receptors. The presence of such diverse chemical constituents makes the species a subject of interest in phytochemistry.
According to a study published by "Natural product communications", the phytochemical investigation of Corydalis crispa resulted in the isolation of 9 known isoquinoline alkaloids. These specific compounds include protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopinne (4), coreximine (5), rheagenine (6), ochrobirine (7), sibiricine (8) and bicuculline (9). Crude extracts of the plant demonstrated significant anti-inflammatory activity with a p < 0.01 value against TNF-alpha production in LPS activated THP-1 cells. Furthermore, compounds 2, 4 and 7 exhibited acetylcholinesterase inhibitory activity. Compound 5 showed antiplasmodial activity against P. falciparum strains TM4/8.2 and K1CB1, although stylopine (4) did not show antimalarial activity against the K1CB1 strain.
The primary medicinal compounds of this plant are shown in the list below.
- 13-oxocryptopine
- 13-oxoprotopine
- 14-O-acetylneoline
- protopine
- sibiricine
What health conditions is this plant used for?
This plant is used for treating autoimmunity, cancer, infectious diseases, inflammatory conditions, and schistosomiasis. Researchers study its bioactive compounds for their potential to modulate immune responses in patients with autoimmune disorders. Its phytochemical properties are also being investigated for their ability to inhibit tumor growth and combat various infectious diseases. Furthermore, the plant shows promise in reducing symptoms associated with chronic inflammatory conditions. Clinical interest also extends to its efficacy in managing schistosomiasis through its antiparasitic effects.
According to a study published by "International journal of molecular sciences", Corydalis crispa is one of five Bhutanese medicinal plants from which 40 phytochemicals were isolated. These plant-derived compounds are emerging as frontline treatment agents for cancer, infectious diseases and autoimmunity. Researchers tested 14 purified compounds, including those from Corydalis crispa, for their immunomodulatory properties using a murine dendritic cell line. The study also evaluated cytotoxicity against a human cholangiocyte cell line using xCELLigence real time cell monitoring. These findings demonstrate that compounds from such medicinal plants can exert mechanisms of action by modulating dendritic cell activity.
The main health conditions this plant is used for are shown in the list below.
- autoimmunity
- cancer
- infectious diseases
- inflammatory conditions
- Schistosomiasis
What are the herbal preparations of this plant?
This plant is Corydalis crispa, a species used to create medicinal herbal preparations such as crude extracts for therapeutic purposes. These crude extracts are often derived from the rhizomes to capture the plant's bioactive alkaloids. Practitioners utilize these preparations to address various ailments involving the nervous and digestive systems. The chemical profile of these extracts provides the foundation for their pharmacological effects. Careful processing ensures that the potent medicinal components remain stable within the final preparation.
According to a study published by "Journal of ethnopharmacology", Corydalis crispa is one of seven Bhutanese medicinal plants used in Bhutanese Traditional Medicine for managing disorders related to inflammatory conditions. Crude extracts of the plant were prepared using 4 different solvents, which included methanol, hexane, dichloromethane and chloroform. In the study, Corydalis crispa gave the best inhibitory activity of the 6 plants that inhibited TNF-α production in LPS-activated THP-1 monocytic cells. This inhibitory activity was determined using cytokine-specific sandwich quantitative enzyme-linked immunosorbent assays. Statistical significance for the results was evaluated using GraphPad Prism version 5.01 with a p-value ≤0.05.
The main herbal preparations of this plant are shown in the list below.
- crude extracts
What side effects this plant can have?
This plant can cause nausea, dizziness, sedation, gastrointestinal upset, and hypotension in individuals who consume it. These adverse reactions often stem from the plant's potent alkaloids which affect the central nervous system. Users may experience significant drowsiness or a sense of lightheadedness shortly after ingestion. Furthermore, the botanical compounds can lead to digestive distress or a noticeable drop in blood pressure. Monitoring these physiological responses is essential for anyone considering the use of this species.
The main side effects this plant can have are shown in the list below.
- Nausea
- Dizziness
- Sedation
- Gastrointestinal upset
- Hypotension
What herbs are paired with Corydalis crispa?
This plant, Corydalis crispa, is traditionally paired with herbs such as Valeriana officinalis, Passiflora incarnata, and Humulus lupulus to enhance its sedative and anxiolytic properties.
These combinations are frequently used in herbal formulations designed to address insomnia and nervous tension. By combining Corydalis crispa with Valerian, practitioners aim to create a synergistic effect that promotes deeper sleep cycles. The addition of Passionflower can further support the calming of mental restlessness during these treatments.
Such pairings are carefully balanced to optimize the plant's ability to soothe the central nervous system.